Place it in its market
Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.
See how Context works →On the price, the facts of the public record●Results filed
With an account, also○dividends▲splits◌next earningswith an account
End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.
Latest on record
The most recent facts, as filed.
Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.
- Aug 4, 2026Quarterly report · 10-QFiled by the company itself.Open the filing ↗
- Aug 4, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
- May 28, 2026Notice of sale · Form 144Alles Institute for Medical Research Corp · Director, 10% Stockholder · $219.3KOpen the filing ↗
In numbers
What this profile holds, counted.
Closes · 1 year250
SEC filings on record1,43411 flagged findings
Reported transactions (Form 4)80since Apr 21, 2026 · and 15 other holdings
Corporate events (8-K)30since Apr 16, 2019
What the record says
Description, identity and filings, each with its source.
Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.
What the company does
Bio-Rad Laboratories, Inc. is an American developer and manufacturer of specialized technological products for the life science research and clinical diagnostics markets. The company was founded in 1952 in Berkeley, California, by husband and wife team David and Alice Schwartz, both graduates of the University of California, Berkeley. Bio-Rad is based in Hercules, California, and has operations worldwide.
Source: Wikipedia (CC BY-SA 4.0) · copied on Sep 3, 2026 · may not reflect recent changes.
Identity
Share class: Class B.
The 25 most recent filings (of 1,434)
Every SEC filing, newest first, with what it is. Below, each type with its own explanation.
Insider transaction · 12 Form 4 filingsshow all 12hide
- Sep 9, 26Form 4 ↗Insider transaction
- Sep 9, 26Form 4 ↗Insider transaction
- Sep 9, 26Form 4 ↗Insider transaction
- Sep 9, 26Form 4 ↗Insider transaction
- Sep 9, 26Form 4 ↗Insider transaction
- Sep 9, 26Form 4 ↗Insider transaction
- Sep 9, 26Form 4 ↗Insider transaction
- Sep 9, 26Form 4 ↗Insider transaction
- Sep 9, 26Form 4 ↗Insider transaction
- Sep 3, 26Form 4 ↗Insider transaction
- Sep 3, 26Form 4 ↗Insider transaction
- Sep 3, 26Form 4 ↗Insider transaction
- Aug 4, 2610-Q ↗Quarterly report
- Aug 4, 268-K ↗Current report · Restructuring plan with committed costs
- Jul 28, 26Form 4 ↗Insider transaction
- May 28, 26Form 144 ↗Notice of proposed sale
- May 13, 26Form 4 ↗Insider transaction
- May 11, 26Form 144 ↗Notice of proposed sale
- Apr 30, 2610-Q ↗Quarterly report
- Apr 30, 268-K ↗Current report · Results · Communication to the market
- Apr 24, 268-K ↗Current report · A senior executive left or was appointed
1,434 filings on record, the oldest from May 12, 94.
Listing the 25 most recent filings of the 1,434 on record.
123032
- Aug 4, 26Restructuring plan with committed costs+3 more in the same filing8-K 2.05 ↗
- Apr 24, 26A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- Jul 28, 25A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- Feb 13, 25Restructuring plan with committed costs+3 more in the same filing8-K 2.05 ↗
4 senior executive changes2024show all 4hide
- Aug 20, 24A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Apr 26, 24A senior executive left or was appointed+3 more in the same filing8-K 5.02 ↗
- Apr 10, 24A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Mar 20, 24A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Feb 14, 24A material agreement was terminated+4 more in the same filing8-K 1.02 ↗
3 senior executive changes2023show all 3hide
- Dec 7, 23A senior executive left or was appointed8-K 5.02 ↗
- Oct 17, 23A senior executive left or was appointed8-K 5.02 ↗
- Aug 25, 23A senior executive left or was appointed8-K 5.02 ↗
- Apr 20, 22Entered a material agreement+2 more in the same filing8-K 1.01 ↗
- Mar 28, 22A senior executive left or was appointed8-K 5.02 ↗
- Nov 18, 21Entered a material agreement+2 more in the same filing8-K 1.01 ↗
- Oct 4, 21A senior executive left or was appointed8-K 5.02 ↗
- Feb 4, 21Restructuring plan with committed costs8-K 2.05 ↗
6 older filings not shown · The record reaches back to Dec 14, 04.
Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.
- Nov 25, 19Restructuring plan with committed costs8-K 2.05 ↗
- Mar 25, 19Listing notice (8-K 3.01)+1 more in the same filing8-K 3.01 ↗
- Mar 22, 18Listing notice (8-K 3.01)+1 more in the same filing8-K 3.01 ↗
- Mar 31, 14Listing notice (8-K 3.01)+1 more in the same filing8-K 3.01 ↗
- Dec 15, 09Listing notice (8-K 3.01)8-K 3.01 ↗
- Dec 9, 09Listing notice (8-K 3.01)+1 more in the same filing8-K 3.01 ↗
- Oct 14, 08Listing notice (8-K 3.01)8-K 3.01 ↗
The full record holds 12 stress filings.
Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.
Schedule 13D: stake and stated purpose
Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.
- Norman D. Schwartz97.2%Sep 25, 25SCHEDULE 13D/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum. · 3 earlier filings
- Alice N. Schwartz12.3%May 1, 25SCHEDULE 13D/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
Schedule 13G: short-form filing
The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.
- First Eagle Investment Management, LLC11.4%Jun 30, 25SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 2 earlier filings
- The Vanguard Group - 23-19459308.4%Sep 30, 24SCHEDULE 13G/A ↗
- BlackRock, Inc.7.4%Sep 30, 25SCHEDULE 13G/A ↗
Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.
No purchases or sales are on record in this stretch; only other transactions (compensation, withholding, exercises or gifts).
Stock compensation, tax and giftsshow the 40 other transactionshide
Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.
- Sep 6, 26Compensationamount n/aNORMAN D SCHWARTZChairman & CEO↗
- Sep 6, 26Tax$716KNORMAN D SCHWARTZChairman & CEO↗
- Sep 6, 26Compensationamount n/aRoop Kalyan LakkarajuEVP, Chief Financial Officer↗
- Sep 6, 26Tax$302KRoop Kalyan LakkarajuEVP, Chief Financial Officer↗
- Sep 6, 26Compensationamount n/aSchwartz Allison↗
- Sep 6, 26Tax$13KSchwartz Allison↗
- Sep 6, 26Compensationamount n/aSEDAT EVRANEVP, Global Supply Chain↗
- Sep 6, 26Tax$107KSEDAT EVRANEVP, Global Supply Chain↗
- Sep 6, 26Compensationamount n/aCOURTNEY C ENLOEEVP, General Counsel & Sec↗
- Sep 6, 26Tax$118KCOURTNEY C ENLOEEVP, General Counsel & Sec↗
- Sep 6, 26Compensationamount n/aJAMES BARRYEVP, President, LSG↗
- Sep 6, 26Tax$181KJAMES BARRYEVP, President, LSG↗
- Sep 6, 26Compensationamount n/aEVA ANETTE ENGELHARDTEVP, President, CDG↗
- Sep 6, 26Tax$187KEVA ANETTE ENGELHARDTEVP, President, CDG↗
- Sep 5, 26Compensationamount n/aNORMAN D SCHWARTZChairman & CEO↗
- Sep 5, 26Tax$1.1MNORMAN D SCHWARTZChairman & CEO↗
- Sep 5, 26Compensationamount n/aRoop Kalyan LakkarajuEVP, Chief Financial Officer↗
- Sep 5, 26Tax$216KRoop Kalyan LakkarajuEVP, Chief Financial Officer↗
- Sep 5, 26Compensationamount n/aJonathan P. DiVincenzoPresident & COO↗
- Sep 5, 26Tax$258KJonathan P. DiVincenzoPresident & COO↗
- Sep 5, 26Compensationamount n/aSchwartz Allison↗
- Sep 5, 26Tax$32KSchwartz Allison↗
- Sep 5, 26Compensationamount n/aSEDAT EVRANEVP, Global Supply Chain↗
- Sep 5, 26Tax$127KSEDAT EVRANEVP, Global Supply Chain↗
- Sep 5, 26Compensationamount n/aCOURTNEY C ENLOEEVP, General Counsel & Sec↗
- Sep 5, 26Tax$95KCOURTNEY C ENLOEEVP, General Counsel & Sec↗
- Sep 5, 26Compensationamount n/aJAMES BARRYEVP, President, LSG↗
- Sep 5, 26Tax$142KJAMES BARRYEVP, President, LSG↗
- Sep 5, 26Compensationamount n/aEVA ANETTE ENGELHARDTEVP, President, CDG↗
- Sep 5, 26Tax$142KEVA ANETTE ENGELHARDTEVP, President, CDG↗
- Sep 5, 26Compensationamount n/aRajat MehtaEVP, GBL Commercial Operations↗
- Sep 5, 26Tax$90KRajat MehtaEVP, GBL Commercial Operations↗
- Sep 5, 26Compensationamount n/aRajat MehtaEVP, GBL Commercial Operations↗
- Sep 5, 26Tax$195KRajat MehtaEVP, GBL Commercial Operations↗
- Sep 1, 26Compensationamount n/aNORMAN D SCHWARTZChairman & CEO↗
- Sep 1, 26Tax$890KNORMAN D SCHWARTZChairman & CEO↗
- Sep 1, 26Compensationamount n/aSchwartz Allison↗
- Sep 1, 26Tax$16KSchwartz Allison↗
- Sep 1, 26Compensationamount n/aJAMES BARRYEVP, President, LSG↗
- Sep 1, 26Tax$59KJAMES BARRYEVP, President, LSG↗
The full record holds 295 transactions and goes back to Feb 10, 23.
Its sector and its market
Bio-Rad Laboratories, Inc. among Health Care companies
The profile shows what is on record. Context and Radar place the company among those of its sector and region.
Browse its neighbours
Other Health Care companies
With an account you also get
- The four engines — growth, trend, risk and context — each with its word and its score.
- The risk band and the sector phase.
- The company's fundamentals and accounts.
- Watchlist: your list of companies, with the «since you follow it» figure.
The research continues
The profile tells the story. The market sets the scene.
From Bio-Rad Laboratories, Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.
See what deserves a closer look
Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.
See how Radar works →Keep the why
Follow Bio-Rad Laboratories, Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.
See an example review →
Coverage
What sits behind this page.
Where each figure comes from and how far it reaches.
- Prices
- End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
- Series quality
- 250 clean closes in the period.
- SEC records
- 1,434 documents on file, from May 12, 1994 to Sep 9, 2026.
- Company description
- Wikipedia, read on Sep 3, 2026.
- This page
- Generated on Oct 19, 2026; refreshed through the day.
Start at your own pace
Explore first. Go deeper with access.
Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.
Compare plans →- No account
This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.
- Pro
What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.
- Pro+
Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.
Are the prices real time?
No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.
Which SEC documents appear here?
Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.
Why does a European company show no SEC records?
It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.
Before forming a view on a company,
read what is on record.
One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.